Pretreatment with P2Y12 inhibitors in ST-elevation myocardial infarction: A systematic review and meta-analysis.

Douglas Mesadri Gewehr,Pedro Emanuel de Paula Carvalho, Caroline Serafim Dagostin,Rhanderson Cardoso, Taiane Belinati Loureiro Kubrusly,Fernando Bermudez Kubrusly,Luiz Fernando Kubrusly

CIRCULATION（2023）

引用 0|浏览2

暂无评分

摘要

Our analysis suggests that pretreatment with oral P2Y12 inhibitors before PCI in patients with STEMI was not associated with reduced all-cause mortality, myocardial infarction, or major bleeding. However, pretreatment with P2Y12 inhibitors in the pre-hospital setting appears to be beneficial in reducing reinfarction.

查看译文

关键词

p2y12 inhibitors,myocardial infarction,st‐elevation st‐elevation

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要